What's breaking now, across thousands of outlets.
Ultragenyx Pharmaceutical is selling a priority review voucher to an undisclosed buyer for $210 million, marking one of the richest sales of the speedy-approval tool so far this year. The California ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
A Dutch court has ordered Merck to stop manufacturing and selling its injectable formulation of Keytruda in eight European countries. The court ruled that Merck infringed one of Halozyme's patents and
Russia has shared little information about how a researcher in Siberia died from a "pneumonia of unknown origin.”
Mumbai: Three months after the Maharashtra Food and Drug Administration (FDA) busted an alleged Rs 11.48-crore synthetic milk racket spread across multiple districts, the investigation has uncovered…
Collins said that veterans should specifically look beyond wait times and focus more on the quality of care they receive.
In renewed policy, pediatricians review the benefits of heating milk to kill germs.
In renewed policy, pediatricians review the benefits of heating milk to kill germs.
